Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$59.53 - $85.11 $38,218 - $54,640
-642 Reduced 18.87%
2,761 $219,000
Q3 2023

Nov 06, 2023

SELL
$69.23 - $79.09 $10,730 - $12,258
-155 Reduced 4.36%
3,403 $256,000
Q2 2023

Aug 08, 2023

SELL
$45.44 - $71.21 $32,398 - $50,772
-713 Reduced 16.69%
3,558 $253,000
Q1 2023

May 08, 2023

BUY
$43.88 - $52.48 $187,411 - $224,142
4,271 New
4,271 $213,000
Q2 2022

Aug 05, 2022

SELL
$34.86 - $63.77 $172,557 - $315,661
-4,950 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$44.33 - $57.82 $59,801 - $77,999
-1,349 Reduced 21.42%
4,950 $286,000
Q4 2021

Feb 07, 2022

BUY
$40.27 - $56.99 $19,410 - $27,469
482 Added 8.29%
6,299 $280,000
Q3 2021

Nov 10, 2021

BUY
$47.43 - $84.23 $58,528 - $103,939
1,234 Added 26.93%
5,817 $280,000
Q2 2021

Aug 04, 2021

SELL
$73.06 - $97.7 $41,717 - $55,786
-571 Reduced 11.08%
4,583 $389,000
Q1 2021

May 10, 2021

SELL
$70.43 - $97.42 $59,302 - $82,027
-842 Reduced 14.04%
5,154 $433,000
Q4 2020

Feb 08, 2021

SELL
$48.9 - $75.26 $15,941 - $24,534
-326 Reduced 5.16%
5,996 $451,000
Q3 2020

Nov 12, 2020

SELL
$37.23 - $50.97 $632 - $866
-17 Reduced 0.27%
6,322 $313,000
Q2 2020

Aug 11, 2020

SELL
$28.78 - $46.83 $9,785 - $15,922
-340 Reduced 5.09%
6,339 $244,000
Q1 2020

May 08, 2020

BUY
$25.53 - $70.14 $44,932 - $123,446
1,760 Added 35.78%
6,679 $206,000
Q4 2019

Feb 11, 2020

BUY
$54.18 - $65.64 $38,088 - $46,144
703 Added 16.67%
4,919 $268,000
Q3 2019

Nov 12, 2019

BUY
$58.58 - $83.91 $11,598 - $16,614
198 Added 4.93%
4,216 $264,000
Q2 2019

Jul 31, 2019

SELL
$63.59 - $78.71 $43,877 - $54,309
-690 Reduced 14.66%
4,018 $303,000
Q1 2019

May 06, 2019

SELL
$50.75 - $80.54 $10,860 - $17,235
-214 Reduced 4.35%
4,708 $369,000
Q4 2018

Feb 13, 2019

SELL
$52.18 - $67.93 $118,083 - $153,725
-2,263 Reduced 31.5%
4,922 $276,000
Q3 2018

Nov 13, 2018

SELL
$38.13 - $68.37 $54,068 - $96,948
-1,418 Reduced 16.48%
7,185 $466,000
Q2 2018

Aug 03, 2018

SELL
$27.62 - $44.51 $78,247 - $126,096
-2,833 Reduced 24.77%
8,603 $350,000
Q1 2018

May 03, 2018

BUY
$26.05 - $34.5 $83,047 - $109,986
3,188 Added 38.65%
11,436 $353,000
Q4 2017

Feb 02, 2018

SELL
$24.5 - $36.01 $26,043 - $38,278
-1,063 Reduced 11.42%
8,248 $212,000
Q3 2017

Nov 03, 2017

BUY
$31.26 - $42.03 $291,061 - $391,341
9,311
9,311 $307,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.